Jorden David Emersoninsider trades

In SEC Form 4 filings, Jorden David Emerson is listed as CEO/CFO of Nuo Therapeutics, Inc. (AURX). In the last 90 days, Jorden David Emerson bought $9.5K of Nuo Therapeutics, Inc. (AURX) on the open market and sold none. The largest purchase was $8.7K of Nuo Therapeutics, Inc. (AURX) on Aug 28.

Companies and roles

Company	Role	Transactions	Last filed
AURXNuo Therapeutics, Inc.	CEO/CFO	2	Aug 31

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-31

Dashed line = amended filing (Form 4/A)

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
AURXNuo Therapeutics, Inc.	Aug 28	Aug 314/A	P	7,984	$1.09	Purchase +$8,695	2,070,000	No	Form 4/A
AURXNuo Therapeutics, Inc.	Aug 27	Aug 314/A	P	789	$1.07	Purchase +$844	2,062,016	No	Form 4/A

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.